Notification of dealings by a director/PDMR
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your APTA notes
Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, today announces that David Bunka, Chief Scientific Officer, on 19 December 2024 purchased 1,317,870 ordinary shares of £0.001 each ("Ordinary Shares") in the Company at a price of 0.3794 pence per Ordinary Share.
Following this transaction, David Bunka's total beneficial interest in the Company is 19,842,070 Ordinary Shares, representing approximately 1.00% of the Company's issued share capital.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | David Bunka |
| 2 | Reason for the notification | |
| a) | Position/status | Chief Scientific Officer |
| b) | Initial notification /Amendment | Initial notification |
| a) | Name | Aptamer Group plc |
| b) | LEI | 213800Y4XGH3WJNBE686 |
| a) | Description of the financial instrument, type of instrument | Ordinary shares of £0.001 each |
| Identification code | GB00BNRRP542 | |
| b) | Nature of the transaction | Purchase of shares |
| c) | Price(s) and volume(s) | Price 0.3794p Volume 1,317,870 |
| d) | Aggregated information | |
| - Aggregated volume | 1,317,870 | |
| - Price | 0.3794p | |
| e) | Date of the transaction | 19 December 2024 |
| f) | Place of the transaction | London Stock Exchange |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.